Maximilian Winter
General Partner at Harmonix
United States
Overview
Work Experience
Founder & General Partner
2017 - Current
Harmonix is a pioneering venture capital firm investing in data-driven platform companies at the nexus of healthcare, life sciences, and critical infrastructure (deep tech). As key drivers of the fourth Industrial Revolution, engineering biology and computational methodologies are paving the way for a new epoch of commercialized scientific progress that enhances human and planetary well-being. The firm is on its third fund, comprising over 40 trailblazing companies that span AI-powered biotechnology, synthetic biology, healthcare, and critical infrastructure with national security implications. Notable breakthroughs include the first AI-designed drug to undergo clinical trials, a groundbreaking fully automated robotic cloud laboratory for synthetic biology research, and the inaugural rideshare satellite launch into orbit. Esteemed publications such as Bloomberg, BBC, Forbes, and Fortune have spotlighted the fund's portfolio companies for their transformative scientific achievements.
Venture capital fund helping entrepreneurs launch exponential organizations generally with an impact or sustainability element.
Member Board of Directors
2015
Board Observer
2021
xCures is an AI-based precision oncology platform that tightly integrates cancer research and care.
Raised $12,965,000.00 from HealthTech Capital.